Biographical Info

ViewsML is a techbio company revolutionizing spatial biology for translational research and clinical diagnostics using AI deep learning. Immunohistochemistry (IHC) is a key laboratory procedure used for biomarker detection. Our core platform technology virtualizes the IHC process to predict biomarker expression spatially and quantitatively, transforming this days-long process into mere seconds. The ROI of our transformative technology is calculated to be 15X for every dollar spent – we give researchers back 100% of their IHC time, 50% of their IHC budget, and enriched sample characterization data that is far beyond what is possible with any competing technology. Our innovation allows for better drug characterization through virtual multiplexing, more precise patient selection in clinical trials and diagnostics, and virtualization of CDx for precision medicines to reach more patients faster.